Two-Year Ban On Device Tax Approved In Tax-Extenders Bill
This article was originally published in The Gray Sheet
Congress passed a two-year moratorium on the 2.3% device excise tax as part of a tax-extenders package, Dec. 18, and President Obama was expected to sign it. The legislation also includes a permanent extension of the research & development tax credit.
You may also be interested in...
US Congress successfully pushed through a user-fee bill in 2017 to help smooth the regulatory path at FDA for medical devices and other products, but other efforts, including several industry priorities, remain undone. On top on the list, of course, is the effort to repeal the device excise tax. But legislation is also on the table to address diagnostics regulation, telehealth reimbursement, and medtech cybersecurity vulnerability, among other issues. Here is a look at the medtech landscape in Congress in 2018.
The Minnesota congressman is taking another stab at chopping off the 2.3 medical device excise tax as part of the wider Obamacare repeal actions anticipated for the new Congress.
Scrip’s on-the-ground team in Asia talks about how the regional and wider pharma industry and policymakers have responded so far to the spreading coronavirus outbreak, with a focus on the expedited development of potential drugs and vaccines.